LyGenesis
Business Services · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1710 Murray Ave Ste 200, Pittsburgh, Pen...Phone Number
(412) 449-9983Website
www.lygenesis.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About LyGenesis
LyGenesis, Inc. is a clinical-stage cell therapy company that focuses on addressing life-threatening diseases such as Type 1 diabetes and end-stage liver and renal disease. Their innovative approach utilizes patients' lymph nodes as bioreactors to grow functioning ectopic organs, significantly improving the economics and logistics of organ transplantation. By employing an outpatient endoscopic ultrasound procedure, their therapies reduce medical risks and costs compared to traditional organ transplants. The company is advancing its pipeline through various phases of clinical trials for multiple organ therapies.Explore more
LyGenesis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LyGenesis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if LyGenesis has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if LyGenesis had a recent Job posting/layoffs
Product Launch: Get notified when LyGenesis launches new products
Check out if LyGenesis is spiking on competitors!
Funding: Get notified immidiatlly once LyGenesis has new funding data
Earning: See what the market has to say on LyGenesis recently announced quarterly report
LyGenesis, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at LyGenesis
Recommended Actions
Reach out to Masked Content who joined LyGenesis as Masked Content
Find 3 more new buyers
Compare Similar Companies to LyGenesis
Compare insights from companies similar to LyGenesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7.7M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
LyGenesis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
LyGenesis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about LyGenesis.
LyGenesis financials insights
Gather financial insights about LyGenesis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Debt
$4M
2020
Debt
$11M
2023
Series A
$19M
LyGenesis Tech Stack
A closer look at the technologies used by LyGenesis
Most Recent Scoops
Funding
Facilities Relocation / Expansion
Facilities Relocation/Expansion
Funding
Funding
Funding
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LyGenesis
Sign Up For FreeTo access detailed company insights
LyGenesis, Inc. is a clinical-stage cell therapy company that focuses on addressing life-threatening diseases such as Type 1 diabetes and end-stage liver and renal disease. Their innovative approach utilizes patients' lymph nodes as bioreactors to grow functioning ectopic organs, significantly improving the economics and logistics of organ transpla... Read More
